Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Allegra Padula
ID:
1b8268a6-2619-30fb-68c4
/
Unclaimed
/
Organization:
Goodwin Procter
Published Works
24 articles
Biocon Announces Supplemental U.S. FDA Approval for Prefilled Autoinjector for YESINTEK
Big Molecule Watch ·
August 28, 2026
cite
Teva Launches AHZANTIVE® Aflibercept Biosimilar in Europe
Big Molecule Watch ·
June 22, 2026
cite
FDA Issues Draft Guidance on Safety Testing for Gene Editing Therapies
Big Molecule Watch ·
May 11, 2026
cite
FDA Releases Congressional Justification for FY 2027 Budget, Including Proposal Regarding Interchangeability of Biosimilars
Big Molecule Watch ·
April 22, 2026
cite
Teva Receives FDA Approval of Denosumab Biosimilar and Filing Acceptances by FDA and EMA For Omalizumab Biosimilar
Big Molecule Watch ·
April 9, 2026
cite
Previous
1
2
...
5
Next